Resource Center

Go back to Resource Center

Effect of the orally administered PKC b Inhibitor, Ruboxistaurin, on sustained moderate visual loss in the PKC-DRS2 Study

2006

Journal Article

Authors:
Brucker, A.; Aiello, L.P.; Vignati, L.; Sheetz, M.J.; Zhi, X.; Girach, A.; Davis, M.D.; Group, R.C.Milton for

Location:
Sao Paulo, Brazil

Go back to Resource Center